We are delighted to announce the high-profile appointment of Dr. Thomas Wolter into our Munich office.
A highly experienced European Patent Attorney, Dr Wolter brings 25 years’ experience gained across a range of proceedings before the European Patent Office, the German Federal Patent Court, the German Federal Court of Justice and the national civil courts in oppositions, nullity actions and infringement suits.
With expertise across the fields of biotechnology and chemistry, Dr Wolter has particular technical expertise in complex patents relating to therapeutic antibodies, human blood plasma products, production and formulation of biologics and more.
His clients include a range of market-leading life sciences brands, including pharmaceutical giant Bristol Myers Squibb, whom he has advised for 25 years.
In addition to client advisory work, Dr Wolter will play a key role in helping drive the commercial growth of the firm’s life science’s work and expanding its client portfolio.
Rapid growth for Munich office
Our Munich office continues to grow rapidly. In addition to Dr Wolter’s arrival, Dr Urs Ferber, a dual-qualified German and European Patent Attorney specialised in biophysics, joins as an Associate in May. The hiring of a senior trade mark attorney is also being finalised. The moves see our Munich headcount grow to 14 in little over two years.
We opened our Munich office in November 2017, offering the full range of range of patent, trade mark and design services, including drafting, prosecution, oppositions, litigation, IP strategy consulting and portfolio management. A series of high-profile lateral hires have seen the team expand rapidly, with the office forced to relocate to larger premises inside 12 months.
Munich partner Tanis Keirstead commented:
“Mewburn Ellis is an ambitious firm focused on attracting the very best of Europe’s leading IP professionals. Dr Wolter’s arrival sends a very clear signal to the market that no other IP firm is better positioned to support Europe’s research and innovation community in their EP patent strategies and wider IP needs”.
Dr Thomas Wolter commented:
“I am delighted to join Mewburn Ellis. The firm has a long-standing reputation for excellence and I look forward to helping propel new growth for the firm here in Germany, across Europe, and globally”.
